Encompass Group LLC is bringing its line of eMax Replacement Support Surfaces to the acute care market.
“With the overwhelmingly positive reception acute care has given our Airisana Therapeutic Support Surface we’re expanding our product offerings in this important market,” said Michelle Daniels, Encompass Group vice president of product strategy and development. “Therapeutic Replacement Support Surfaces are critical in providing proper pressure management and ensuring patient comfort. And now, with eMax, we’re offering the acute care market a complete range of choices.”
The eMax portfolio includes three-tiered construction of high-quality, polyurethane foam in these variations: eMax Reassure. With a top layer of viscoelastic foam from head to toe, it provides immersion and protection against skin breakdown; eMax Classic, with a designated viscoelastic foam and sloped heel section, it provides added protection for the hard-to-care-for heels and lower legs; eMax Gentle delivers head-to-toe rotation for extended periods of clinical efficacy. Additional options are also available to support patients with behavioral health and bariatric care needs.
All eMax replacement surfaces include features to assist health care professionals in this difficult time of resources and fatigue, such as: Firm side rails, designed to support patient or resident transport, facilitate ingress/egress, and to remind the patient or resident that he or she is near the edge of the surface. Inverted seams and a unique, patent-pending band design help prevent infection and infestation. Nylon or multi-way stretch covers are available, and three-tiered, zoned construction of high-quality polyurethane aids in pressure reduction and helps ensure optimal performance.
All eMax surfaces are available in widths up to 60 inches and lengths up to 96 inches.
“Here at Encompass, we’ve worked hard to develop and deliver surface options for every health care industry need. Bringing eMax to the acute care market is one more way we’re doing that.” Daniels concluded.
For more information, visit https://hubs.ly/Q01c0GJTO.